Long-form analysis at the intersection of AI and life sciences — all spells, sorted by time.
In 2026, NMN entered its first clinical trial for autoimmune disease and appeared in Nature Medicine. Combined with new evidence on T cell senescence reversal and exercise-driven SIRT1 activation, three studies map NAD+ as an immune calibrator.
A few years ago, a startup was charging people tens of thousands of dollars to infuse them with plasma from young donors. The FDA eventually issued a statement:
There's a contradiction sitting at the center of anti-aging biology that doesn't get explained enough: some researchers are working hard to increase autophagy
Mechanical ventilation is one of modern medicine's most important life-saving tools. For patients in respiratory failure, it is the bridge between death and sur
Most people know that poor sleep makes them feel older. But does it actually make them biologically older — in a way measurable in their blood?A 2026 systemat
Age-related macular degeneration — in its dry form — has no approved treatment that meaningfully stops its progression. It affects tens of millions of people wo